1. Describe the outcomes of chemotherapy regimens studies in relapsed rhabdomyosarcoma.
2. Describe the targeted and immune based therapies being studied in patients with relapsed rhabdomyosarcoma.
3. Describe the role of stem cell transplant in patients with relapsed rhabdomyosarcoma.
12/06/2018 - 1:00pm to 2:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Amir Siddiqui, MD